The Ulthera System will now be available to treat the décolletage or décolleté in select Asian countries, the company has announced.
The new décolletage indication will utilize the System’s same technology to encourage the natural formation of collagen and elastin on the chest. For the décolletage, this lifting effect can result in a gradual reduction of chest wrinkles over 3 months, with continued improvement possible for up to 6 months post-procedure.
“Launching the décolletage treatment in Asia is just the tip of the iceberg. We anticipate an exciting second half of 2012 with even more international indications on the horizon as well as additional countries where System clearance is anticipated,” says Ulthera CE0 Matthew Likens in a press release.
Ulthera is initiating a multi-country tour in Asia to introduce the new clinical indication to practitioners.
The new clinical indication will not be commercially available in all Asian countries, including those that do not currently offer Ultherapy as well as Singapore and Hong Kong where the System is only cleared to treat the face. Ulthera is approved by the FDA for noninvasive brow lifts.